Rasha
Cairo, Cairo Governorate, 002, Egypt
NCT Number: NCT02775747
There is limited application of the use of PRP in obstetrics, therefore there is a need for assessment if it is efficacy in improving skin wound healing in cesarean section.
Looking for future studies?
Notify Me25 year–35 year
Female
Interventional
Phase 1 / Phase 2
Cairo, Cairo Governorate, 002, Egypt
This study aims to assess the efficacy of injection of platelet rich plasma into the wound of recurrent cesarean section for improving wound healing and enhancing the shape of the wound in women undergoing cesarean section.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Platelet rich plasma is prepared from fresh whole blood which is collected from a peripheral vein stored in acid citrare dextrose solution A (ACD-A)anticoagulant and processed to increase platelets by separating various components of blood
Other names: PRP, platelete rich plasma (PRP)
64 controlled women with recurrent cesarean section and fullfit to all inclusion and exclusion craiteria will reseve saline injection at time of wound closure
Time frame: one month
Efficacy of PRP in Wound healing in cesarean section by 100 mm visual analog scale (VAS) for wound healing
Time frame: one month
Assessment of the Cosmetic results of the wound by Modified Vancouver scar scale
Ain Shams University
Other
Platelet Rich Plasma Gel in Wound Closure in Recurrent Cesarean Section:Randomized Controlled Trial
Acronym: PRP-CS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04053413
Cicatrix, Decision Making, Shared
Chapel Hill, North Carolina, United States
View Trial DetailsNCT02827591
Cicatrix, Fibrosis
Halle, Saxony-Anhalt, Germany
View Trial DetailsNCT02827604
Cicatrix, Fibrosis
Halle, Saxony-Anhalt, Germany
View Trial DetailsNCT02703519
Cicatrix, Complications; Cesarean Section, Wound, Dehiscence
Halle, Saxony-Anhalt, Germany
View Trial Details